Among FV, most patients (n = 75, 32.3%) were in the age category of 45 to 64 years (data not shown).
Most of these patients were elderly [median 71 (IQR 64 76) years (data not shown)], could not drive a car, could not take public transportation, and generally, they did not leave their home.
There was no statistically significant difference in sensitivity to 5FU, paclitaxel, docetaxel, adriamycin and cyclophosphamide between women aged ≤45 years or ≥65 years (data not shown).
Nevertheless, the number of responder T cells and the amount of IFN-γ released was higher in the HCWs with previous positive TST results performed in the last 5 years (data not shown).
Also, the women lost to follow-up were proportionally younger, i.e. of women younger than 44 years of age 83% could be followed (898/1080 = 83%) compared to 88% (3863/4394) of women aged 45-59 years (data not shown).
Females were less likely to have been delivered by forceps (ORca = 0.31, 95%CI 0.13 0.77, p = 0.01), were lighter at birth and were more likely to be born in earlier years (data not shown).
The results were similar over years (data not shown).
The role of the public sector varied between survey years (data not shown).
The mean age of the population was 44 years (data not shown).
The age distribution is similar to that reported during previous years (data not shown).
This shape was similar in the previous years (data not shown).
